Estrogen receptor alpha-negative (ER−) and triple-negative breast cancer (TNBC) account for a smaller proportion of breast cancer types but are among the most aggressive malignancies with limited treatment strategies when compared to less aggressive ER + tumors [1]. Here, ESR1 is linked to breast cancer.